Pioglitazone use and risk of bladder cancer: population based cohort study (Q34676639)

27029385

3 August 2017

title

Pioglitazone use and risk of bladder cancer: population based cohort study (English)

1 reference

3 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Marco Tuccori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Hui Yin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Oriana H Yu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Robert W Platt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Laurent Azoulay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

30 March 2016

1 reference

3 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

i1541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

2 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

The risk of bladder cancer in korean diabetic subjects treated with pioglitazone.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

7 July 2018

Thiazolidinedione safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone and bladder cancer: a propensity score matched cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone and bladder cancer: a population-based study of Taiwanese.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Validity of diagnostic coding within the General Practice Research Database: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Immortal time bias in pharmaco-epidemiology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone use and the risk of bladder cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Cancer recording and mortality in the General Practice Research Database and linked cancer registries

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

NICE issues guidance on diabetes treatments

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816602

Pioglitazone: are rumours of its death exaggerated?

26 October 2018

1 reference

12 December 2020

Pioglitazone: reports of its death are greatly exaggerated - it is alive and ready to resume saving lives

1 reference

12 December 2020

Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes

1 reference

12 December 2020

Assessing interactions of binary time-dependent covariates with time in cox proportional hazards regression models using cubic spline functions

1 reference

12 December 2020

Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!

1 reference

12 December 2020

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.I1541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

27029385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029385%20AND%20SRC:MED&resulttype=core&format=json